Par Pharmaceutical and its team of dedicated healthcare professionals bring new, high-quality products to market that are the therapeutic equivalent of the brand-name pharmaceuticals. Our generic drug portfolio consists of numerous products across a wide range of therapeutic areas. We are focused on niche, high-barrier-to-entry products that have limited competition and long life cycles.
Founded in 1978, today the #5 ranked ...
Par Pharmaceutical and its team of dedicated healthcare professionals bring new, high-quality products to market that are the therapeutic equivalent of the brand-name pharmaceuticals. Our generic drug portfolio consists of numerous products across a wide range of therapeutic areas. We are focused on niche, high-barrier-to-entry products that have limited competition and long life cycles.
Founded in 1978, today the #5 ranked US generic company*
Employs approximately 1,550 professionals in offices in Woodcliff Lake(Corporate Headquarters) and Parsippany (Sales), New Jersey; Spring Valley, New York; Irvine, California; Rochester, Michigan, and Chennai, India (Research & Development and Manufacturing); and in Suffern, New York (Distribution)
An experienced Authorized Generics partner of choice for many of the world’s leading pharmaceutical companies
Has introduced generic versions of several major pharmaceutical products, including Entocort EC®, Rythmol SR®, Toprol-XL®, Maxalt-MLT®, Lamictal® XR, Luvox CR®, Zometa®, Wellbutrin XL® and Tussionex®.
Conducts manufacturing in the United States and abroad and markets and/or licenses more than 80 prescription drug product families
Has manufacturing plant capacity of more than 3 billion tablets per year
Strong distribution relationships in place at top US retail chains, wholesalers, distributors, managed care organizations, mail order pharmacies and group purchasing organizations
Operational excellence in quality and compliance; achieved >99% trade-service levels
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.